Solutions
keyboard_arrow_downServices
keyboard_arrow_downSupport & Resources
keyboard_arrow_downCompany
keyboard_arrow_downContact
humidity_low Sample Type:
Serum
update Time to Result:
Under 60 Minutes
During the early stages of kidney dysfunction, there are typically no symptoms of kidney injury, and it may only be detected through a blood or urine test done for another reason. Early detection and treatment can help prevent Acute Kidney Injury (AKI) from progressing. If left untreated, it can progress to kidney failure, where dialysis or a kidney transplant may be necessary to maintain life.
| Biochip Markers | ||
|---|---|---|
| sTNFR1 | sTNFR2 | |
| H-FABP | Midkine | |
Application
To facilitate the early diagnosis of kidney dysfunction.
- Normal High (No Symptoms)
- Randox Biochip Diagnoses
- Mild Disease
- Mild - Moderate Disease
- Moderate - Severe Disease
- Earliest diagnosis by current technology
- Severe Disease
- Systematic Failure
Early Diagnosis can make a difference
Acute Kidney Injury Test
Biochip Array provides preoperative risk assessment and postoperative risk monitoring to triage patients undergoing cardiac or orthopaedic surgery to mitigate the possibility of acute kidney injury (AKI). Current triaging is inadequate, as in most cases where creatinine is elevated and eGFR is decreased kidney damage has already started. With 615,000 cases per year in the UK, Biochip can reduce costs and could save £600 million.
download The Kidney Dysfunction AKI FlyerDiabetic Kidney Disease Test
Biochip Array provides risk assessment and monitoring of diabetic patients in clinic to triage patients and identify progression of Diabetic Kidney Disease (DKD). A recent study demonstrated four biomarkers which could be used to clinically predict the progression of type 2 diabetes to DKD. Biochip is the only product on the market which allows for simultaneous measurement of the four markers within 60 minutes.
download The Kidney Dysfunction DKD FlyerRead paper on the blood and urinary cytokine balance and renal outcomes at orthopaedic surgery
download DownloadBenefits
Early Intervention
Patients undergoing cardiac or orthopaedic trauma surgery are at risk of developing AKI. Biochip can facilitate early intervention, mitigating the chances of developing AKI and reducing mortality and morbidity rates.
Improved Triaging
Current triaging is inadequate; in most cases where creatinine is elevated and eGFR is decreased, kidney damage has already started. Biochip provides predictive biomarkers to identify patients who are at risk of AKI, improving triaging.
Shorter ICU Stays
Drastically decrease time spent in ICU, making more beds available for additional patients.
Resource Optimisation
Precision medicine reduces unnecessary use of supplies, shortens ICU stays and enables better use of staff resources.
The Evidence MultiSTAT
Evidence MultiSTAT
The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.
Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.
With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.
MultiSTAT Cartridge
The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.
The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.
No other components are required.
Get in touch to discover more
To find out more about the Evidence MultiSTAT or to discuss arranging a demo, enquire now.